CJC-1295
Also known as: Mod GRF 1-29, CJC-1295 DAC, CJC-1295 no DAC
The GHRH Amplifier
A GHRH analog that amplifies growth hormone release. Often stacked with Ipamorelin for synergistic effects.
How It Works
Simple Explanation
Extends the duration of natural GH release by mimicking growth hormone releasing hormone (GHRH).
Technical Details
Modified GHRH analog with increased half-life. DAC version provides sustained release; no-DAC version allows pulsatile dosing.
Pharmacokinetics & Storage
Half-Life
~30 minutes (no DAC) / ~8 days (with DAC)
Duration in circulation
Storage Requirements
Reconstitute with bacteriostatic water. DAC version is more stable but requires different dosing protocol.
Research Timeline: What Studies Have Observed
Based on clinical trial data and published research. Individual responses may vary significantly.
Week 1
Research shows initial GH elevation begins. When stacked with GHRP, synergistic effects observed from first dose.
Weeks 2-4
Studies document improved sleep quality and recovery. GH-mediated benefits begin accumulating.
Weeks 5-8
Clinical research indicates body composition changes becoming noticeable. Enhanced recovery from training well-established.
Weeks 12+
Research suggests continued improvements in lean mass, fat loss, and anti-aging markers. Optimal results with 3-6 month protocols.
Benefits
- Amplified GH release when stacked
- Improved body composition
- Enhanced recovery
- Better sleep quality
- Synergy with secretagogues
Potential Side Effects
Flushing
Common initially
Water retention
Occasional
Fatigue
Rare
Known Interactions
Based on clinical research and pharmacological studies. Always consult a healthcare provider about potential interactions.
Ipamorelin/GHRPs
monitorIntentionally combined in research for synergistic GH release. CJC-1295 amplifies the pulse triggered by GHRPs.
Insulin
cautionBoth affect glucose metabolism. Research protocols time doses carefully, typically using peptides when fasted.
Somatostatin/Octreotide
avoidSomatostatin inhibits GH release. These would antagonize CJC-1295 effects.
Research Highlights
CJC-1295/Ipamorelin Combination (2023)
Synergistic GH release confirmed when combined with ipamorelin in clinical settings
View StudyFrequently Asked Questions
What's the difference between CJC-1295 with and without DAC?
Why combine CJC-1295 with ipamorelin?
Is Mod GRF 1-29 the same as CJC-1295 no DAC?
What's the flushing side effect?
Who Is It For
- GH optimization seekers
- Stack with Ipamorelin
- Athletes
- Anti-aging protocols
Who Should Avoid
- Cancer history
- Active malignancy
- Pregnant/nursing
How It Compares
Research-based comparisons with similar peptides. Individual responses and circumstances should guide decisions.
Sermorelin is the original GHRH analog with extensive clinical use. CJC-1295 has improved stability and potency. Both work through GHRH pathway.
Different pathway - ipamorelin triggers GH via ghrelin receptors. Often combined rather than used as alternatives.
Research Dosing Protocols
Common Research Protocol
No DAC: 100mcg 2-3x daily. DAC: 2mg weekly
Administration Frequency (per studies)
No DAC: 2-3x daily. DAC: 1-2x weekly
Delivery Methods
👃 This peptide is also available in nasal spray form from select suppliers.
Available Forms
- • Subcutaneous injection
⚠️ Not Medical Advice: Dosing information is compiled from published research and clinical studies for educational purposes only. This is not a recommendation. All peptide research should be conducted by qualified professionals in controlled research environments. Consult a healthcare provider before considering any protocol.
Cost Context
Research-grade CJC-1295 (no DAC): $30-60 per 2mg vial. DAC version: $40-80 per 2mg. Monthly costs: No DAC $60-150/month, DAC $40-80/month due to less frequent dosing.
Prices vary by region, source, and insurance coverage. This is general context only.
Related Peptides
⚠️ Important Disclaimer
This information is for educational purposes only and is not medical advice. Many peptides discussed are research compounds not approved for human use by the FDA. Always consult with a qualified healthcare provider before starting any peptide protocol. PepGains does not sell peptides and is not responsible for how this information is used. All timeline and efficacy information is based on published research and clinical trials - individual results may vary significantly.